Larvol Delta - Diabetes-and-microalbuminuria-in-heart-transplant-recipients--insights-from-baseline-characteristics-of-the-Empagliflozin-in-Heart-Transplant-EMPAHTx-trial

Jardiance (empagliflozin) - Eli Lilly, Boehringer Ingelheim

Lisa Raven1,2,3; Christopher Muir1,2; Peter Macdonald3,4,5; Andrew Jabbour3,4,5; Jerry Greenfield1,2,3,4

Sep 17, 2026